Ceftazidime–Avibactam Pharmacokinetic Comparative In Vivo/In Vitro Study in a Critically Ill Children Under High‐Volume Continuous Venovenous Hemodiafiltration
ABSTRACT Ceftazidime–avibactam is a novel cephalosporin/beta‐lactamase inhibitor combination developed to address increasing antimicrobial resistance. This report presents a comparative study of the pharmacokinetics of ceftazidime and avibactam, utilizing in vitro data derived from two experiments w...
Saved in:
| Main Authors: | Michael Thy, Alexandre Debs, Gabrielle Lui, Leo Froelicher‐Bournaud, Jean‐Marc Tréluyer, Mehdi Oualha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Pharmacology Research & Perspectives |
| Online Access: | https://doi.org/10.1002/prp2.70139 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Continuous Venovenous Hemofiltration versus Continuous Venovenous Hemodiafiltration in Critically Ill Patients: A Retrospective Cohort Study from a Canadian Tertiary Centre
by: Farhan AlEnezi, et al.
Published: (2014-01-01) -
Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia
by: Yi-Tsung Lin, et al.
Published: (2025-09-01) -
Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
by: Bongjin Lee, et al.
Published: (2018-01-01) -
The Impact Of Ceftazidime-Avibactam Utilization In Hospital Setting
by: Shobana Selvaganesan, et al.
Published: (2024-12-01) -
Variability in Uremic Control during Continuous Venovenous Hemodiafiltration in Trauma Patients
by: Sigrid Beitland, et al.
Published: (2012-01-01)